These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1170913)

  • 1. Proceedings: Aversive properties of naloxone in morphine-treated rats.
    Pilcher CW; Stolerman IP
    Br J Pharmacol; 1975 Jun; 54(2):235P. PubMed ID: 1170913
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of morphine tolerance and withdrawal on intestinal salt and water transport in the rat in vivo and in vitro.
    Warhurst G; Smith GS; Higgs N; Tonge A; Turnberg LA
    Gastroenterology; 1984 Nov; 87(5):1035-41. PubMed ID: 6541171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aversive properties of opiate withdrawal studied in rats.
    Mucha RF; Gritti MD; Kim C
    NIDA Res Monogr; 1986; 75():567-70. PubMed ID: 3123976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
    Wei E; Sigel SS; Loh HH; Way EL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of naloxone-precipitated morphine withdrawal on c-fos expression in rat corticotropin-releasing hormone neurons in the paraventricular hypothalamus and extended amygdala.
    Hamlin AS; Buller KM; Day TA; Osborne PB
    Neurosci Lett; 2004 May; 362(1):39-43. PubMed ID: 15147776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine withdrawal increases intrinsic excitability of oxytocin neurons in morphine-dependent rats.
    Brown CH; Stern JE; Jackson KL; Bull PM; Leng G; Russell JA
    Eur J Neurosci; 2005 Jan; 21(2):501-12. PubMed ID: 15673449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of naloxone and naltrexone on the development of the morphine withdrawal syndrome].
    Piccinelli D; de Feo G; Mazzanti G
    Boll Soc Ital Biol Sper; 1986 Oct; 62(10):1221-8. PubMed ID: 3828120
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of ketamine, naloxone and morphine in the rat.
    Fidecka S
    Pol J Pharmacol Pharm; 1987; 39(1):33-40. PubMed ID: 3671186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.
    Popik P; Danysz W
    J Pharmacol Exp Ther; 1997 Feb; 280(2):854-65. PubMed ID: 9023300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
    Kimes AS; London ED
    J Pharmacol Exp Ther; 1989 Feb; 248(2):538-45. PubMed ID: 2918470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats.
    Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W
    Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Naloxone and naltrexone antagonism of various central effects of morphine].
    Piccinelli D; de Feo G; Mazzanti G
    Boll Soc Ital Biol Sper; 1986 Oct; 62(10):1213-20. PubMed ID: 3828119
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence.
    Cicero TJ; Meyer ER
    J Pharmacol Exp Ther; 1973 Feb; 184(2):404-8. PubMed ID: 4734581
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
    Kimura M; Tokumura M; Itoh T; Inoue O; Abe K
    Neurosci Lett; 2006 Aug; 404(1-2):107-11. PubMed ID: 16753260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone increases vascular responsiveness in chronic morphine treated rats and facilitates intracellular signaling in cultured vascular cells.
    Wang Y; Xu JG; Yu YQ; Wang HY; Jiang B; Li XY
    Acta Pharmacol Sin; 2001 Oct; 22(10):881-6. PubMed ID: 11749769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus.
    Holmes PV; de Bartolomeis A; Koprivica V; Crawley JN
    Synapse; 1995 Mar; 19(3):197-205. PubMed ID: 7540319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine and naloxone-induced opiate withdrawal: a comparison between clonidine and morphine in man.
    Fantozzi R; Luciani G; Masini E; Blandina P; Mannaioni P
    Subst Alcohol Actions Misuse; 1980; 1(4):369-73. PubMed ID: 7302789
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats.
    Chang AP; Dixon WR
    J Pharmacol Exp Ther; 1990 Sep; 254(3):857-63. PubMed ID: 2395117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.